×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SANJIVANI PARANTERAL LTD. | NA | NA | NA | NA | 301.0 | 37.1 |
| Nureca Limited | 369.16 | 5.52 | 343.24 | 0.55 | 278 | |
| Lotus Eye Hospital And Institu | 137.04 | 5.45 | 135.17 | 0.26 | 264 | 406.0 |
Sanjivani Paranteral Ltd., with Security Code 531569, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.1 | 8.1 | 12.6 | 14.0 | 15.0 | 12.9 | 16.4 | 18.1 | 17.3 | 18.2 |
| Expenses | 8.2 | 6.7 | 10.6 | 11.9 | 13.0 | 10.7 | 14.1 | 15.3 | 14.8 | 15.5 |
| Operating Profit | 0.9 | 1.4 | 2.0 | 2.1 | 2.0 | 2.2 | 2.3 | 2.9 | 2.6 | 2.7 |
| OPM % | 10.12% | 17.56% | 15.99% | 15.1% | 13.09% | 16.78% | 14.22% | 15.74% | 14.7% | 14.67% |
| Other Income | 0.3 | 0.0 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.4 | 0.3 | 0.4 |
| Interest | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | 0.2 | 0.2 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Profit before tax | 1.0 | 1.0 | 1.8 | 2.0 | 1.9 | 1.9 | 2.3 | 2.9 | 2.5 | 2.7 |
| Tax % | 0% | -0.1% | -13.9% | -14.1% | -13.2% | -33.2% | -24.6% | -21.3% | -24.4% | -15% |
| Net Profit | 1.0 | 1.0 | 1.6 | 1.7 | 1.7 | 1.3 | 1.7 | 2.3 | 1.9 | 2.2 |
| EPS in Rs | 0.95 | 1 | 1.55 | 1.71 | 1.65 | 1.08 | 1.47 | 1.96 | 1.62 | 0 |
| Metrics | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 18.1 | 17.3 | 18.2 |
| Expenses | 15.3 | 14.8 | 15.5 |
| Operating Profit | 2.9 | 2.6 | 2.7 |
| OPM % | 15.74% | 14.7% | 14.67% |
| Other Income | 0.4 | 0.3 | 0.4 |
| Interest | 0.2 | 0.2 | 0.2 |
| Depreciation | 0.1 | 0.2 | 0.2 |
| Profit before tax | 2.9 | 2.5 | 2.7 |
| Tax % | -21.3% | -24.4% | -15.1% |
| Net Profit | 2.3 | 1.9 | 2.2 |
| EPS in Rs | 1.96 | 1.62 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 19% |
| 3 Years: | 33% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 38% |
| 3 Years: | 63% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 105% |
| 3 Years: | 63% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 105% |
| 3 Years: | 63% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|